Stockscreener 앱 받기
34.65
13.59%
-5.45
시간 외 거래:
35.40
0.75
+2.16%
전일 마감가:
$40.10
열려 있는:
$41
하루 거래량:
28,909
Relative Volume:
0.79
시가총액:
$211.89M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-15.07
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
-14.84%
1개월 성능:
-9.70%
6개월 성능:
-28.50%
1년 성능:
+6,200%
1일 변동 폭
$34.65
$41.49
1주일 범위
$34.65
$42.50
52주 변동 폭
$0.3438
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
명칭
Monopar Therapeutics Inc
전화
(847) 388-0349
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
34.65 | 248.58M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-19 | 재개 | Piper Sandler | Overweight |
| 2025-01-10 | 개시 | Piper Sandler | Overweight |
| 2024-10-11 | 개시 | Rodman & Renshaw | Buy |
| 2021-01-28 | 개시 | ROTH Capital | Buy |
모두보기
Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스
Applying Elliott Wave Theory to Monopar Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Chart based exit strategy for Monopar Therapeutics Inc.Predictive System for Long-Term Stock Forecast - Newser
Does Monopar Therapeutics Inc. fit your quant trading modelConservative Investment Setup and Risk Analysis - Newser
How Monopar Therapeutics Inc. stock performs during market volatilityStock Price Prediction Using AI Tools - Newser
Monopar Therapeutics Inc. stock volume spike explainedSwing Trade Timing with Daily Forecast - Newser
What makes Monopar Therapeutics Inc. stock price move sharplyWeekly Chart-Based Forecast for Traders - Newser
How to monitor Monopar Therapeutics Inc. with trend dashboardsStock Holding Strategy Long-Term Summary Sheet - Newser
Does Monopar Therapeutics Inc. qualify in momentum factor screeningShort-Term Stock Trend Forecast Guide - Newser
When is the best time to buy Monopar Therapeutics Inc. stockFree Weekly Hot Picks With Buy Confidence - Newser
Can swing trading help recover from Monopar Therapeutics Inc. lossesSmart Entry Watchlist with Daily Analysis - Newser
What momentum shifts mean for FWONAPattern Breakout Prediction for Short Term - Newser
How to use a screener to detect Monopar Therapeutics Inc. breakoutsHigh Confidence Strategy with Trend Alignment - Newser
Is Monopar Therapeutics Inc. showing signs of accumulationShort Term Momentum Based Trading Strategy - Newser
Why Monopar Therapeutics Inc. stock attracts strong analyst attentionFree Fundamental + Technical Hybrid Stock Tips - Newser
Monopar Therapeutics MNPR Q2 2025 Earnings Preview Downside Risk Amid Increased Operating Expenses - AInvest
Is it too late to sell Monopar Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser
Monopar Therapeutics Inc expected to post a loss of 47 cents a shareEarnings Preview - TradingView
Will Monopar Therapeutics Inc. stock go up soonEntry Timing Tracker with Alert Accuracy - Newser
Forecasting Monopar Therapeutics Inc. price range with options dataPredictable Entry Strategy With Technical Backing - Newser
Is Monopar Therapeutics Inc. a good long term investmentDiscover undervalued stocks before they soar - Jammu Links News
How strong is Monopar Therapeutics Inc. company’s balance sheetBuild a diversified portfolio for steady profits - Jammu Links News
What drives Monopar Therapeutics Inc. stock priceAchieve rapid portfolio appreciation today - Jammu Links News
Is Monopar Therapeutics Inc. a growth stock or a value stockBuild wealth steadily with smart stock selection - Jammu Links News
When is Monopar Therapeutics Inc. stock expected to show significant growthInvest smarter with data-backed trading alerts - Jammu Links News
What are the latest earnings results for Monopar Therapeutics Inc.Capitalize on fast-moving stock opportunities - Jammu Links News
What are the technical indicators suggesting about Monopar Therapeutics Inc.Capitalize on market momentum for profits - Jammu Links News
Monopar Therapeutics Inc. stock trend outlook and recovery pathFundamental + Technical Combined Watchlist - Newser
What are analysts’ price targets for Monopar Therapeutics Inc. in the next 12 monthsIdentify undervalued stocks ready to soar - Jammu Links News
How many analysts rate Monopar Therapeutics Inc. as a “Buy”Free Trend-Following Techniques - Jammu Links News
Will Monopar Therapeutics Inc. price bounce be sustainableFree Fundamental Growth Stock Analysis - Newser
Combining price and volume data for Monopar Therapeutics Inc.Investment Timing Strategy with Market Filters - newser.com
Is it the right time to buy Monopar Therapeutics Inc. stockExponential return rates - Jammu Links News
How volatile is Monopar Therapeutics Inc. stock compared to the marketHigh-yield market plays - Jammu Links News
What is the dividend policy of Monopar Therapeutics Inc. stockBuild a diversified portfolio for steady profits - Jammu Links News
What are Monopar Therapeutics Inc. company’s key revenue driversDaily Trading Picks Backed By Experts - Jammu Links News
Why is Monopar Therapeutics Inc. stock attracting strong analyst attentionEarnings Report Alerts With Proven Results - Jammu Links News
Monopar Therapeutics (MNPR) Projected to Post Earnings on Friday - Defense World
Monopar Therapeutics Inc (MNPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):